Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B
- 31 December 2001
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Hepatology
- Vol. 35 (6), 749-755
- https://doi.org/10.1016/s0168-8278(01)00218-5
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Fibrosis in Patients with Chronic Hepatitis C: Detection and SignificanceSeminars in Liver Disease, 2000
- Impact of Interferon Alfa-2b and Ribavirin on Progression of Liver Fibrosis in Patients With Chronic Hepatitis CHepatology, 2000
- New aspects of hepatic fibrosisJournal of Hepatology, 2000
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesThe New England Journal of Medicine, 1999
- Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infectionJournal of Hepatology, 1999
- Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: A dynamic viewGastroenterology, 1999
- Natural history of liver fibrosis progression in patients with chronic hepatitis CThe Lancet, 1997
- Structure of the Extracellular Matrix in Normal and Fibrotic Liver: Collagens and GlycoproteinsSeminars in Liver Disease, 1990
- Cellular Sources of Noncollagenous Matrix Proteins: Role of Fat-Storing Cells in FibrogenesisSeminars in Liver Disease, 1990
- Collagen polymorphism in normal and cirrhotic human liver.JCI Insight, 1977